Akademisyen

İREM KIRIŞ

DOKTOR ÖĞRETİM ÜYESİ

BAHÇEŞEHİR ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

Makale 15
Proje 0
Kitap 0
Bildiri 0
Patent 0
Sanatsal 0

Scopus (SJR) Q1 9 Q2 6 Q3 0 Q4 0

WoS (JCR) Q1 3 Q2 6 Q3 6 Q4 0

TR Index 2 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0

Üst %10 makale 2

Ort. yüzdelik 64.9%

Üst %1 payı 0.0%

Üst %10 payı 13.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Makale listesi

2025 Proteomic signatures and mitochondrial dysfunctions in peripheral T cells reveal novel ınsights into Alzheimer's disease SCIENTIFIC REPORTS DOI 10.1038/s41598-025-22783-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.5%
2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.1%
2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.1%
2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
2022 Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer?s disease patients NEUROSCIENCE LETTERS DOI 10.1016/j.neulet.2022.136799 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.3%
2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain MOLECULAR OMICS DOI 10.1039/d1mo00440a YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%
2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.1%
2020 Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity Cancer Medicine DOI 10.1002/cam4.3223 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.9%
2020 Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity Wiley DOI 10.1002/cam4.3223 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.9%

Akademisyenlere dön